Amel Mézlini

1.7k total citations
125 papers, 1.0k citations indexed

About

Amel Mézlini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Amel Mézlini has authored 125 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Oncology, 28 papers in Pulmonary and Respiratory Medicine and 26 papers in Cancer Research. Recurrent topics in Amel Mézlini's work include Sarcoma Diagnosis and Treatment (14 papers), Cancer-related molecular mechanisms research (10 papers) and Genetic factors in colorectal cancer (9 papers). Amel Mézlini is often cited by papers focused on Sarcoma Diagnosis and Treatment (14 papers), Cancer-related molecular mechanisms research (10 papers) and Genetic factors in colorectal cancer (9 papers). Amel Mézlini collaborates with scholars based in Tunisia, France and Bahrain. Amel Mézlini's co-authors include Sabrina Zidi, Mouna Ayadi, Besma Yacoubi‐Loueslati, Mouna Stayoussef, Wassim Y. Almawi, Nancy Uhrhammer, Nejla Stambouli, Nadia Kourda, Karim Bougatef and Farhat Ben Ayed and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Amel Mézlini

115 papers receiving 1.0k citations

Peers

Amel Mézlini

ONCOL

IMMUN

SURGE

Cindy McGrath United States

Eoghan E. Mooney Ireland

Heloísa de Andrade Carvalho Brazil

Simona Secondino Italy

Hsiu‐Hao Chang Taiwan

Jiří Špaček Czechia

Mark T. Wakabayashi United States

Roberta Schiavo Italy

Francesco Multinu Italy

Su‐Cheng Huang Taiwan

Cindy McGrath United States

Amel Mézlini

356 ×0.8

ONCOL

187 ×0.6

IMMUN

168 ×0.8

269 ×1.4

SURGE

175 ×0.9

Citations per year, relative to Amel Mézlini Amel Mézlini (= 1×) peers Cindy McGrath

Countries citing papers authored by Amel Mézlini

Since Specialization

Citations

This map shows the geographic impact of Amel Mézlini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amel Mézlini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amel Mézlini more than expected).

Fields of papers citing papers by Amel Mézlini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amel Mézlini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amel Mézlini. The network helps show where Amel Mézlini may publish in the future.

Co-authorship network of co-authors of Amel Mézlini

This figure shows the co-authorship network connecting the top 25 collaborators of Amel Mézlini. A scholar is included among the top collaborators of Amel Mézlini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amel Mézlini. Amel Mézlini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guerfali, Fatma Z., Lamia Charfi, Amel Mézlini, et al.. (2024). VISTA/CTLA4/PD1 coexpression on tumor cells confers a favorable immune microenvironment and better prognosis in high-grade serous ovarian carcinoma. Frontiers in Oncology. 14. 1352053–1352053. 3 indexed citations

Mézlini, Amel, et al.. (2023). Variant Characterization of a Representative Large Pedigree Suggests “Variant Risk Clusters” Convey Varying Predisposition of Risk to Lynch Syndrome. Cancers. 15(16). 4074–4074.

Çiçin, İrfan, Amel Mézlini, Slim Ben Ahmed, et al.. (2021). An Open-Label, Multinational, Multicenter, Phase IIIb Study with Subcutaneous Administration of Trastuzumab in Patients with HER2-Positive Early Breast Cancer to Evaluate Patient Satisfaction. SHILAP Revista de lepidopterología. 18(1). 63–73. 2 indexed citations

Ayadi, Mouna, et al.. (2020). A practical approach to the management of colorectal cancer during the COVID-19 crisis in the reference cancer treatment center in Tunisia. Journal of Oncology Pharmacy Practice. 26(8). 1931–1933. 2 indexed citations

Sghaier, Ikram, et al.. (2020). Western influenced lifestyle and Kv2.1 association as predicted biomarkers for Tunisian colorectal cancer. BMC Cancer. 20(1). 1086–1086. 12 indexed citations

Sghaier, Ikram, et al.. (2020). KCNB1 gene polymorphisms and related indel as predictor biomarkers of treatment response for colorectal cancer – toward a personalized medicine. Tumor Biology. 42(6). 2904802869–2904802869. 5 indexed citations

Charfi, Lamia, et al.. (2020). The Management of Desmoid Tumors: A Retrospective Study of 30 Cases. International Journal of Surgical Oncology. 2020. 1–7. 6 indexed citations

Mokrani, A., et al.. (2020). 1573P Anxiety and depression in cancer patients during the COVID-19 pandemic: A single-centre study. Annals of Oncology. 31. S957–S958. 8 indexed citations

Mézlini, Amel, et al.. (2019). Association of common IL-10 promoter gene variants with the susceptibility to head and neck cancer in Tunisia. TURKISH JOURNAL OF MEDICAL SCIENCES. 49(1). 123–128. 10 indexed citations

10.

Stayoussef, Mouna, et al.. (2019). Interleukin-17A polymorphisms predict the response and development of tolerance to FOLFOX chemotherapy in colorectal cancer treatment. Cancer Gene Therapy. 27(5). 311–318. 7 indexed citations

11.

Schairer, Catherine, Ahmed Hablas, Rabab Gaafar, et al.. (2019). Clinico-pathologic and mammographic characteristics of inflammatory and non-inflammatory breast cancer at six centers in North Africa. Breast Cancer Research and Treatment. 176(2). 407–417. 13 indexed citations

12.

Ayadi, Mouna, et al.. (2015). Perioperative chemotherapy in locally advanced gastric cancer. A retrospective study about 25 cases.. PubMed. 93(4). 228–30. 5 indexed citations

13.

Zidi, Sabrina, et al.. (2015). Interleukin-1 Gene Cluster Polymorphisms and its Haplotypes may Predict the Risk to Develop Cervical Cancer in Tunisia. Pathology & Oncology Research. 21(4). 1101–1107. 11 indexed citations

14.

Marrakchi, Raja, Amel Mézlini, Nejla Stambouli, et al.. (2014). Significant association between interleukin-17A polymorphism and colorectal cancer. Tumor Biology. 35(7). 6627–6632. 43 indexed citations

15.

Kourda, Nadia, Yves‐Jean Bignon, Nancy Uhrhammer, et al.. (2013). Positive link between variant Toll-like receptor 4 (Asp299Gly and Thr399Ile) and colorectal cancer patients with advanced stage and lymph node metastasis. Tumor Biology. 35(1). 545–551. 29 indexed citations

16.

Mézlini, Amel, et al.. (2012). HLA class II susceptibility to cervical cancer among Tunisian women. Bulletin du Cancer. 99(9). E81–E86. 14 indexed citations

17.

Kourda, Nadia, Amel Mézlini, Farid Zerimech, et al.. (2011). Lynch syndrome in Tunisia: first description of clinical features and germline mutations. International Journal of Colorectal Disease. 26(4). 455–467. 13 indexed citations

18.

Charafe‐Jauffret, Emmanuelle, Karima Mrad, Sana Intidhar Labidi‐Galy, et al.. (2007). Inflammatory breast cancers in Tunisia and France show similar immunophenotypes. The Breast. 16(4). 352–358. 15 indexed citations

19.

Mézlini, Amel, et al.. (2007). Inflammatory breast cancer in Tunisia in the era of multimodality therapy. Annals of Oncology. 19(3). 473–480. 31 indexed citations

20.

Ayed, Farhat Ben, et al.. (2002). [Dispensation of opioids by pharmacists in Tunisia].. PubMed. 56(6). 711–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact